Article
Dopamine D3 receptor Ser9Gly polymorphism and risperidone response.
Journal of clinical psychopharmacology - 1 Feb 2005
Lane Hsien-Yuan, Hsu Shih-Kuan, Liu Yi-Ching, Chang Yue-Cune, Huang Chiung-Hsien, Chang Wen-Ho
Abstract excerpt
Risperidone is an atypical antipsychotic agent with efficacy for both positive and negative symptoms of schizophrenia. Risperidone is a potent dopamine D3 antagonist and agonism at D3 sites induces behavioral suppression in rodents. We thus hypothesized that D3 antagonism may contribute to response to risperidone in negative symptoms. This study aimed to explore the influence of the Ser9Gly polymorphism of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
